Anti-mouse LCN2 polyclonal, anti-human
€265.00
In stock
SKU
IMD-12050
Polyclonal Antibody against Mouse LCN2
Application: ELISA, WB, IP
Host: Rabbit
INTRODUCTION
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), 24p3, or neutrophil lipocalin (NL), is a 25-kDa secretory glycoprotein. LCN2 has been implicated in a variety of cellular processes including the innate immune response, differentiation, tumorigenesis, and cell survival. It appears to be upregulated in various inflammation and infection conditions. Several reports suggest that LCN2 may represent a sensitive biomarker for various renal injuries and is associated with several types of cancers, including breast cancer, ovarian, colorectal, and pancreatic cancers. Furthermore, a growing body of evidence suggests that serum levels of lipocalin-2 are correlated with obesity, insulin resistance, coronary heart disease and fatty liver disease in humans.
IMMUNOGEN: Recombinant full-length mouse LCN2 expressed in E.coli.
SPECIFICITY: The antibody detects circular mouse LCN2.
FORMULATION: Liquid in phosphate-buffered saline (PBS).
STORAGE:
Store at –20°C for less than one week. For long-term STORAGE: , aliquot and freeze at -70°C. Avoid repeated freeze/defrost cycles.
APPLICATION/ USAGE
Western blot, ELISA and immunostaining.
PURIFICATION: Antigen affinity-purified
PUBLICATIONS CITING THIS PRODUCT
Ye D, Yang K, Zang S, Lin Z, Chau HT, Wang Y, Zhang J, Shi J, Xu A, Lin S, Wang Y. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2. Journal of hepatology. 2016 Nov 1;65(5):988-97.
Ye D, Yang K, Zang S, Lin Z, Chau HT, Wang Y, Zhang J, Shi J, Xu A, Lin S, Wang Y. Corrigendum to “Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2”. Journal of hepatology. 2017 Mar 1;66(3):669.
Sun WY, Bai B, Luo C, Yang K, Li D, Wu D, Félétou M, Villeneuve N, Zhou Y, Yang J, Xu A. Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury. JCI insight. 2018 Sep 6;3(17).
Application: ELISA, WB, IP
Host: Rabbit
INTRODUCTION
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), 24p3, or neutrophil lipocalin (NL), is a 25-kDa secretory glycoprotein. LCN2 has been implicated in a variety of cellular processes including the innate immune response, differentiation, tumorigenesis, and cell survival. It appears to be upregulated in various inflammation and infection conditions. Several reports suggest that LCN2 may represent a sensitive biomarker for various renal injuries and is associated with several types of cancers, including breast cancer, ovarian, colorectal, and pancreatic cancers. Furthermore, a growing body of evidence suggests that serum levels of lipocalin-2 are correlated with obesity, insulin resistance, coronary heart disease and fatty liver disease in humans.
IMMUNOGEN: Recombinant full-length mouse LCN2 expressed in E.coli.
SPECIFICITY: The antibody detects circular mouse LCN2.
FORMULATION: Liquid in phosphate-buffered saline (PBS).
STORAGE:
Store at –20°C for less than one week. For long-term STORAGE: , aliquot and freeze at -70°C. Avoid repeated freeze/defrost cycles.
APPLICATION/ USAGE
Western blot, ELISA and immunostaining.
PURIFICATION: Antigen affinity-purified
PUBLICATIONS CITING THIS PRODUCT
Ye D, Yang K, Zang S, Lin Z, Chau HT, Wang Y, Zhang J, Shi J, Xu A, Lin S, Wang Y. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2. Journal of hepatology. 2016 Nov 1;65(5):988-97.
Ye D, Yang K, Zang S, Lin Z, Chau HT, Wang Y, Zhang J, Shi J, Xu A, Lin S, Wang Y. Corrigendum to “Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2”. Journal of hepatology. 2017 Mar 1;66(3):669.
Sun WY, Bai B, Luo C, Yang K, Li D, Wu D, Félétou M, Villeneuve N, Zhou Y, Yang J, Xu A. Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury. JCI insight. 2018 Sep 6;3(17).
| Is Featured? | No |
|---|
Write Your Own Review